SavedAdd your journal

Journals / Turkish Journal of Surgery / 2021 / Cilt: 37 - Sayı: 4

Risk factors for necrotic cholecystitis during the COVID-19 pandemic: the ChoCO-WSES prospective collaborative study’s experience

Belinda De SİMONE
Elie CHOUİLLARD
Fausto CATENA
Salomone Di SAVERİO
Massimo SARTELLİ
Fikri M. ABU-ZİDAN
Mauro PODDA
Walter L BİFFL
Luca ANSALONİ
Federico COCCOLİNİ
Ernest E MOORE
Yoram KLUGER
Carlos Augusto GOMES
Ferdinando AGRESTA
Pages
387–393
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The ChoCO-W study is conceived to be the largest prospective study to assess the management of patients presenting with acute cholecystitis during the COVID-19 pandemic and risk factors correlated with necrotic cholecystitis to improve the management of high-risk patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: During the COVID-19 pandemic, several studies have reported a decrease in in the admission surgical patients and emergency surgical procedures, and an increase in more severe septic surgical diseases, such as necrotic cholecystitis.
📊
Key Findings & Data:Moreover early data from COVID-19 pandemic reported an increase in the incidence of necrotic cholecystitis among COVID-19 patients.
💡
Conclusion & Impact:Conclusion: The ChoCO-W study is conceived to be the largest prospective study to assess the management of patients presenting with acute cholecystitis during the COVID-19 pandemic and risk factors correlated with necrotic cholecystitis to improve the management of high-risk patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: During the COVID-19 pandemic, several studies have reported a decrease in in the admission surgical patients and emergency surgical procedures, and an increase in more severe septic surgical diseases, such as necrotic cholecystitis. It was probably due to to a critical delay in time-todiagnosis and time-to-intervention resulting to limited access to the operating theatres as well as intensive care units. Early laparoscopic cholecystectomy is the standard of care for acute cholecystitis. Moreover early data from COVID-19 pandemic reported an increase in the incidence of necrotic cholecystitis among COVID-19 patients. The ChoCO-W prospective observational collaborative study was conceived to investigate the incidence and management of acute cholecystitis under the COVID-19 pandemic. Material and Methods: The present research protocol was. conceived and designed as a prospective observational international collaborative study focusing on the management of patients with to the diagnosis of acute cholecystitis under the COVID-19 pandemic. The study obtained the approval of the local Ethics Committee (Nimes, France) and meet and conform to the standards outlined in the Declaration of Helsinki. Eligible patients will be prospectively enrolled in the recruitment period and data entered in an online case report form. Results: The ChoCO-W study will be the largest prospective study carried out during the first period of the COVID-19 pandemic with the aim to investigate the management of patients with acute cholecystitis, in the lack of studies focusing on COVID-19 positive patients. Conclusion: The ChoCO-W study is conceived to be the largest prospective study to assess the management of patients presenting with acute cholecystitis during the COVID-19 pandemic and risk factors correlated with necrotic cholecystitis to improve the management of high-risk patients.

🔖

Cite This Article

SİMONE, B. D., CHOUİLLARD, E., CATENA, F., SAVERİO, S. D., SARTELLİ, M., ABU-ZİDAN, F. M., PODDA, M., BİFFL, W. L., ANSALONİ, L., COCCOLİNİ, F., MOORE, E. E., KLUGER, Y., GOMES, C. A., AGRESTA, F. (2021). Risk factors for necrotic cholecystitis during the COVID-19 pandemic: the ChoCO-WSES prospective collaborative study’s experience. Turkish Journal of Surgery, Cilt: 37 - Sayı: 4, 387–393. https://ajindex.com/articles/417603

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Bourikian S, Anand RJ, Aboutanos M, Wolfe LG, Ferrada P. Risk factors for acute gangrenous cholecystitis in emergency general surgery patients. Am J Surg 2015; 210(4): 730-3
  2. Önder A, Kapan M, Ülger BV, Oğuz A, Türkoğlu A, Uslukaya Ö. Gangrenous cholecystitis: mortality and risk factors. Int Surg 2015, 100(2): 254-60
  3. Gomes CA, Soares C, Di Saverio S, Sartelli M, de Souza Silva PG, Orlandi AS, et al. Gangrenous cholecystitis in male patients: a study of prevalence and predictive risk factors. Ann Hepatobiliary Pancreat Surg 2019; 23(1): 34-40
  4. Asti E, Lovece A, Bonavina L. Gangrenous cholecystitis during hospitalization for SARS-CoV2 infection. Updates Surg 2020; 72(3): 917- 19
  5. Bruni A, Garofalo E, Zuccalà V, Currò G, Torti C, Navarra G, et al. Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis. World J Emerg Surg 2020; 15(1): 43
  6. Alhassan SM, Iqbal P, Fikrey L, Mohamed Ibrahim MI, Qamar MS, Chaponda M, et al. Post COVID 19 acute acalculous cholecystitis raising the possibility of underlying dysregulated immune response, a case report. Ann Med Surg (Lond) 2020; 60: 434-7
  7. Mattone E, Sofia M, Schembari E, Palumbo V, Bonaccorso R, Randazzo V, et al. Acute acalculous cholecystitis on a COVID-19 patient: a case report. Ann Med Surg (Lond) 2020; 58: 73-5
  8. Yokoe M, Hata J, Takada T, Strasberg SM, Asbun HJ, Wakabayashi G, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci 2018; 25(1): 41-54
  9. Okamoto K, Suzuki K, Takada T, Strasberg SM, Asbun HJ, Endo I, et al. Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis. J Hepatobiliary Pancreat Sci 2018; 25(1): 55-72
  10. Pisano M, Allievi N, Gurusamy K, Borzellino G, Cimbanassi S, Boerna D, et al. 2020 World Society of Emergency Surgery updated guidelines for the diagnosis and treatment of acute calculus cholecystitis. World J Emerg Surg 2020; 15(1): 61
  11. Campanile FC, Podda M, Arezzo A, Botteri E, Sartori A, Guerrieri M, et al. Acute cholecystitis during COVID-19 pandemic: a multisocietary position statement. World J Emerg Surg 2020; 15(1): 38
  12. Rickham PP. Human experimentation. Code of ethics of the world medical association. Declaration of Helsinki. Br Med J 1964; 2(5402): 177. 13. de Simone B, Chouillard E, Di Saverio S, Pagani L, Sartelli M, Biffl WL, et al. Emergency surgery during the COVID-19 pandemic: what you need to know fo